PAVmed Net Income From Continuing Ops from 2010 to 2026
| PAVM Stock | USD 10.80 0.22 2.08% |
Net Income From Continuing Ops | First Reported 2014-06-30 | Previous Quarter -12.3 M | Current Value -6 M | Quarterly Volatility 13.9 M |
Check PAVmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 907 K, Interest Expense of 49.2 K or Selling General Administrative of 15.8 M, as well as many indicators such as Price To Sales Ratio of 2.21, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 2.4. PAVmed financial statements analysis is a perfect complement when working with PAVmed Valuation or Volatility modules.
PAVmed | Net Income From Continuing Ops | Build AI portfolio with PAVmed Stock |
Evaluating PAVmed's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into PAVmed Inc's fundamental strength.
Latest PAVmed's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of PAVmed Inc over the last few years. It is PAVmed's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
PAVmed Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (15,055,041) | |
| Geometric Mean | 7,342,541 | |
| Coefficient Of Variation | (244.35) | |
| Mean Deviation | 26,681,142 | |
| Median | (1,776,600) | |
| Standard Deviation | 36,787,069 | |
| Sample Variance | 1353.3T | |
| Range | 131.7M | |
| R-Value | (0.17) | |
| Mean Square Error | 1403.4T | |
| R-Squared | 0.03 | |
| Significance | 0.52 | |
| Slope | (1,214,057) | |
| Total Sum of Squares | 21652.6T |
PAVmed Net Income From Continuing Ops History
About PAVmed Financial Statements
PAVmed investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how PAVmed Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 25.6 M | 26.9 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of PAVmed Correlation against competitors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.00) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.